These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9359727)
61. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement. Betz SJ; Page N; Estrade C; Isliker H J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382 [TBL] [Abstract][Full Text] [Related]
62. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708 [TBL] [Abstract][Full Text] [Related]
63. Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli strain J5, as measured by ELISA. Law BJ; Marks MI J Infect Dis; 1985 Jun; 151(6):988-94. PubMed ID: 3889174 [TBL] [Abstract][Full Text] [Related]
64. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Murphy TF; Bartos LC Infect Immun; 1989 Oct; 57(10):2938-41. PubMed ID: 2476393 [TBL] [Abstract][Full Text] [Related]
65. Evolution of the ferric enterobactin receptor in gram-negative bacteria. Rutz JM; Abdullah T; Singh SP; Kalve VI; Klebba PE J Bacteriol; 1991 Oct; 173(19):5964-74. PubMed ID: 1717434 [TBL] [Abstract][Full Text] [Related]
66. Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous Gram-negative bacterial pneumonia. Chen WH; Kang TJ; Bhattacharjee AK; Cross AS Innate Immun; 2008 Oct; 14(5):269-78. PubMed ID: 18809651 [TBL] [Abstract][Full Text] [Related]
67. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis. Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390 [TBL] [Abstract][Full Text] [Related]
68. Comparison of serological specificity of anti-endotoxin sera directed against whole bacterial cells and core oligosaccharide of Escherichia coli J5-tetanus toxoid conjugate. Lukasiewicz J; Jachymek W; Niedziela T; Malik-Gebicka M; Dzieciatkowska M; Lugowski C Acta Biochim Pol; 2002; 49(3):721-34. PubMed ID: 12422242 [TBL] [Abstract][Full Text] [Related]
69. Properties of equine anti-lipopolysaccharide hyperimmune plasma: binding to lipopolysaccharide and bactericidal activity against gram-negative bacteria. Wells MT; Gaffin SL; Gregory M; Coovadia Y J Med Microbiol; 1987 Nov; 24(3):187-96. PubMed ID: 3669052 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of the opsonic capacity of core lipopolysaccharide antiserum of equine origin against smooth Escherichia coli 0111:B4, using macrophage chemiluminescence. Morris DD; Harmon BG; Moore JN Am J Vet Res; 1989 Aug; 50(8):1272-8. PubMed ID: 2675693 [TBL] [Abstract][Full Text] [Related]
71. Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae. Ito JI; Wunderlich AC; Lyons J; Davis CE; Guiney DG; Braude AI J Infect Dis; 1980 Oct; 142(4):532-7. PubMed ID: 6777436 [TBL] [Abstract][Full Text] [Related]
72. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. Tesh VL; Duncan RL; Morrison DC J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676 [TBL] [Abstract][Full Text] [Related]
73. Immunogenic cross-reaction among outer membrane proteins of Gram-negative bacteria. Xu C; Wang S; Zhaoxia Z; Peng X Int Immunopharmacol; 2005 Jul; 5(7-8):1151-63. PubMed ID: 15914320 [TBL] [Abstract][Full Text] [Related]
76. Immunological studies of an antigen common to many gram-negative bacteria with special reference to E. coli. Characterization and biological significance. Kaijser B Int Arch Allergy Appl Immunol; 1975; 48(1):72-81. PubMed ID: 803931 [TBL] [Abstract][Full Text] [Related]
77. Antibody immunotherapy of gram-negative bacterial sepsis. Dunn DL Pharmacotherapy; 1987; 7(2):S31-5. PubMed ID: 3299299 [TBL] [Abstract][Full Text] [Related]
78. Outer membrane permeabilization by the membrane attack complex sensitizes Gram-negative bacteria to antimicrobial proteins in serum and phagocytes. Heesterbeek DAC; Muts RM; van Hensbergen VP; de Saint Aulaire P; Wennekes T; Bardoel BW; van Sorge NM; Rooijakkers SHM PLoS Pathog; 2021 Jan; 17(1):e1009227. PubMed ID: 33481964 [TBL] [Abstract][Full Text] [Related]
79. Immunization against nosocomial infection. Braude AI; Ziegler EJ; McCutchan JA; Douglas H Am J Med; 1981 Feb; 70(2):463-6. PubMed ID: 7008592 [TBL] [Abstract][Full Text] [Related]
80. Chicken egg antibodies for prophylaxis and therapy of infectious intestinal diseases. IV. In vitro studies on protective effects against adhesion of enterotoxogenic Escherichia coli to isolated enterocytes. Jüngling A; Wiedemann V; Kühlmann R; Erhard M; Schmidt P; Lösch U Zentralbl Veterinarmed B; 1991 Jul; 38(5):373-81. PubMed ID: 1681635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]